Similar articles

• Polymerized serum albumin beads possessing slow release properties for use in vaccines.

  Martin ME, Dewar JB, Newman JF. Martin ME, et al. Vaccine. 1988 Feb;6(1):33-8. doi: 10.1016/0264-410x(88)90011-4. Vaccine. 1988. PMID: 3128017
• Formulation, stability, and delivery of live attenuated vaccines for human use.

  Burke CJ, Hsu TA, Volkin DB. Burke CJ, et al. Crit Rev Ther Drug Carrier Syst. 1999;16(1):1-83. Crit Rev Ther Drug Carrier Syst. 1999. PMID: 10099898 Review.
• Particulate delivery systems for biodefense subunit vaccines.

  Bramwell VW, Eyles JE, Oya Alpar H. Bramwell VW, et al. Adv Drug Deliv Rev. 2005 Jun 17;57(9):1247-65. doi: 10.1016/j.addr.2005.01.010. Epub 2005 Apr 18. Adv Drug Deliv Rev. 2005. PMID: 15935873 Review.
• Oral delivery of poly(lactide-co-glycolide) encapsulated vaccines.

  Jones DH, Partidos CD, Steward MW, Farrar GH. Jones DH, et al. Behring Inst Mitt. 1997 Feb;(98):220-8. Behring Inst Mitt. 1997. PMID: 9382743 Review.
• DNA vaccines for biodefence.

  Garmory HS, Perkins SD, Phillpotts RJ, Titball RW. Garmory HS, et al. Adv Drug Deliv Rev. 2005 Jun 17;57(9):1343-61. doi: 10.1016/j.addr.2005.01.013. Epub 2005 Apr 13. Adv Drug Deliv Rev. 2005. PMID: 15935877 Review.